As a synthetic decapeptide structurally derived from gonadotropin-releasing hormone (GnRH), Triptorelin has long attracted research interest due to its unusually paradoxical signalling profile.

Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner Neurocrine Biosciences Inc. (“Neurocrine”) has initiated and dosed the first patient (s) in a Phase 2 ...

I ate 1,000 sardines in a month and two bizarre things happened: I smelled and obtained a strange superpower. New science ...

Do dragonflies see like humans? Researchers discovered dragonflies use a red-sensing opsin identical to mammals. This study ...

ACCG-2671 is an oral small molecule amylin receptor agonist which acts through complementary satiety pathways in the ...

There is growing demand for treatments that can safely prevent and reverse bone loss over time. Osteoporosis, a condition that weakens bones and makes ...

The accelerated cellular aging and altered gene activity in early-onset colorectal cancer, when not caused by inherited ...

Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone ...

Opioids such as morphine, oxycodone and fentanyl provide pain relief by binding to mu-opioid receptors, which are specialized ...

Performance driven by core drug discovery, continued adoption in environmental toxicology, and launch of new assays and ...

Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the multibillion-dollar market ...